APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,210,000 | +25.0% | 46,751 | -12.8% | 1.63% | +12.4% |
| Q3 2021 | $1,768,000 | -47.8% | 53,642 | 0.0% | 1.45% | -44.4% |
| Q2 2021 | $3,390,000 | +47.3% | 53,642 | 0.0% | 2.61% | +36.4% |
| Q1 2021 | $2,302,000 | -25.0% | 53,642 | 0.0% | 1.92% | -30.4% |
| Q4 2020 | $3,068,000 | +89.6% | 53,642 | 0.0% | 2.75% | +58.3% |
| Q3 2020 | $1,618,000 | -7.6% | 53,642 | 0.0% | 1.74% | -12.5% |
| Q2 2020 | $1,752,000 | +21.9% | 53,642 | 0.0% | 1.99% | +0.3% |
| Q1 2020 | $1,437,000 | -12.5% | 53,642 | 0.0% | 1.98% | +17.2% |
| Q4 2019 | $1,643,000 | – | 53,642 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |